• Users Online: 333
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Instructions to authors Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2022  |  Volume : 9  |  Issue : 3  |  Page : 170-174

Analysis of risk factors and clinical trends in post-COVID oral mucormycosis


1 Department of Orthodontics and Dentofacial Orthopedics, University College of Medical Sciences, New Delhi, India
2 Department of Dentistry, University College of Medical Sciences, New Delhi, India

Correspondence Address:
Dr. Neha Bhutiani
Department of Orthodontics and Dentofacial Orthopedics, University College of Medical Sciences, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/sjoralsci.sjoralsci_44_22

Rights and Permissions

Introduction: The COVID-associated surge in mucormycosis cases was seen during the middle and latter of 2021. Mucormycosis is a rapidly destructive opportunistic fungal infection causing severe morbidity and mortality. Aim: This study aims to identify the risk factors associated with post-COVID oral mucormycosis and analysis of the observed clinical pattern. Materials and Methods: The current study is a retrospective observational one based on demographics, history, and clinical presentation of 46 patients with dental referrals for mucormycosis admitted at the COVID-19 designated facility during the ferocious second wave of COVID-19 in India. Results and Discussion: The incidence of post-COVID mucormycosis was found to be higher in males (29) than females (17), with an average age of 54.5 years in males and 50.8 years in females. All patients belonged to poor/lower socioeconomic backgrounds with a history of hypertension (barring four patients), Type 2 diabetes mellitus, poor oral hygiene, and compromised periodontal health. The right maxilla showed the greatest incidence. The median size of the lesion was found to be 2.22 cm2 with an interquartile range of 1.135 cm2 to 3.2 cm2. Conclusion: The vulnerability of COVID-19 patients to the development of oral mucormycosis was found to be higher for patients with preexisting diabetes mellitus, hypertension, poor socioeconomic background, poor oral hygiene, and periodontal health with greater incidence in maxilla and predilection for the right side.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed144    
    Printed0    
    Emailed0    
    PDF Downloaded23    
    Comments [Add]    

Recommend this journal